ArticleJCI insight2026

Islets co-engineered with thrombomodulin and CD47 achieve sustained survival in allogeneic recipients without chronic immunosuppression.

Shadab Kazmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.